Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Naftifine and Terbinafine Gels in Onychomycosis
NCT00253305Phase 2Completed
- Sponsor
- MediQuest Therapeutics
- Start
- Sep 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of naftifine, Terbinafine in onychomycosis, sponsored by MediQuest Therapeutics. Started Sep 2005; status: completed.
02
Drugs
naftifineTerbinafine
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT00253305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00253305.